# Roflumilast

NDC: 0904-7483
Generic name: Roflumilast
Labeler / Manufacturer: Major Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20240522

FDA application: ANDA208256

## Active ingredients

- ROFLUMILAST: 500 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0904-7483"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0904-7483
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ca22f3e0-6f33-4f1c-97e5-0c962891067a